Kersten Dirk's Form 4 filing
Dyne Therapeutics, Inc. (DYN) · filed Aug 12, 2024
- Accession no.
- 0000950170-24-095402
- Filed
- Aug 12, 2024
- Trade date
- Aug 8-9, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions. Open-market sales total $7.88M. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0000950170-24-096987 (Aug 14, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kersten DirkCIK 0001823682 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2024 | Common Stock | SSaleDisposed | −6,377 | $40.74F2 | −$259,798.98 | 6,410,416 | Indirect | |
| Aug 8, 2024 | Common Stock | SSaleDisposed | −16,357 | $42.97F4 | −$702,860.29 | 6,394,059 | Indirect | |
| Aug 8, 2024 | Common Stock | SSaleDisposed | −68,936 | $42.87F5 | −$2,955,286.32 | 6,325,123 | Indirect | |
| Aug 9, 2024 | Common Stock | SSaleDisposed | −50,736 | $42.55F6 | −$2,158,816.8 | 6,274,387 | Indirect | |
| Aug 9, 2024 | Common Stock | SSaleDisposed | −40,268 | $43.44F7 | −$1,749,241.92 | 6,234,119 | Indirect | |
| Aug 9, 2024 | Common Stock | SSaleDisposed | −1,160 | $44.04F8 | −$51,086.4 | 6,232,959 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $40.60 to $41.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in the footnotes of this Form 4.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $41.605 to $42.435, inclusive.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $42.465 to $43.23, inclusive.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $41.985 to $42.98, inclusive.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $42.99 to $43.98, inclusive.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $43.995 to $44.06, inclusive.
Referenced by the price of 1 transaction in Table I.